Article 5T935 Covid live: fourth vaccine dose ‘could be needed against Omicron’; not enough data on severity, says WHO

Covid live: fourth vaccine dose ‘could be needed against Omicron’; not enough data on severity, says WHO

by
Jem Bartholomew (now), Léonie Chao-Fong , Tom Amb
from on (#5T935)

Latest updates: German health minister says offensive booster campaign' needed to fight variant; WHO official says it is too early to draw conclusions on severity

Researchers in Melbourne, Australia, have turned one of the world's most-used blood-thinning drugs into a nasal spray which they hope could prevent Covid-19 transmission.

Northern Health medical divisional director Don Campbell and researchers at Melbourne, Monash and Oxford Universities found that heparin can block the transmission of Covid-19 and prevent infection.

It won't matter if a new variant comes along, this drug will block that protein from infecting the cells.

I'm very confident that we can demonstrate that it will work, and people will be using this before they go to the shops and before they go to school."

Due to large-scale flooding near the Port of Vancouver ... and the global supply chain crunch caused by the coronavirus pandemic, there are delays in the supply of potatoes."

Continue reading...
External Content
Source RSS or Atom Feed
Feed Location http://feeds.theguardian.com/theguardian/world/rss
Feed Title
Feed Link http://feeds.theguardian.com/
Reply 0 comments